Comparative genomic hybridization (CGH) was used to screen for genomic imbalances in cell lines derived from 13 nonpapillary renal-cell carcinomas (RCCs), two papillary RCCs, one renal squamous-cell carcinoma, and one transitional-cell carcinoma of the renal pelvis. Aberrations were found in all 17 lines. The most frequent changes in nonpapillary RCC cell lines were gains of 5q (85%), 7q (69%), 8q (69%) and 1q (54%) and losses of 3p (92%), 8p (77%), 4q (62%) and 14q (54%). High-level gains (HLGs) were detected at 4q12, 5p, 5q23-33, 7q22-qter, 8q23-24, 10q21-qter, 12p and 12q13-22. By means of fluorescence in situ hybridization (FISH) we narrowed the smallest common region involving 5q gains to the genomic segment between D5S642 and D5S673, and found that the HLG at 4q12 possibly involved amplifications of c-kit and PDGFRA. Two papillary RCC cell lines showed gains of entire chromosomes 7, 12 and 17. The CGH data reported here should help to facilitate the choice of individual renal-tumor cell lines for exploring target genes in regions of interest.
Renal carcinomas comprise a heterogeneous group of tumors that together account for 2-3% of all cancers in adults. 1) Renal-cell carcinoma (RCC), which originates in the renal cortex, accounts for 80-85% of primary malignancies of the kidney.
2) Cytogenetic and molecular genetic studies separate RCC into two types: nonpapillary tumors characterized by abnormalities of chromosome 3p and papillary tumors, which do not show 3p abnormalities. 3) Other histologic types, including transitional cell carcinoma (TCC) of the renal pelvis, make up the remaining 15-20% of renal cancers in adults. 4) Cytogenetic studies have implicated a number of chromosomal loci as important in development and progression of RCC. 3) As with other solid tumors, an accumulation of genetic events may be responsible for tumor progression in the kidney. 5, 6) However, the genetic changes that occur in renal tumorigenesis are not well understood, because the karyotypes of RCCs and their cell lines are extremely complex and involve several poorly characterized marker chromosomes.
Comparative genomic hybridization (CGH) permits analysis of DNA copy-number gains and losses across the entire genome in a single hybridization experiment. 7) Theoretically, all DNA copy-number aberrations (CNAs) spanning two megabases (Mb) or more can be detected by CGH 8) ; moreover, chromosomal regions showing highlevel gains (HLG) indicative of gene amplification can provide useful targets for positional cloning of protooncogenes. [9] [10] [11] [12] Here we report patterns of gains, losses, and amplifications of chromosomal material among 17 renal cancerderived cell lines consisting of 15 RCCs, one renal squamous-cell carcinoma (SCC), and one renal TCC, achieved by CGH and fluorescence in situ hybridization (FISH) together with standard Q-banding. Immortalized RCC cell lines provide an inexhaustible source of DNA and RNA, as well as models for biological and functional studies designed to provide information essential for cloning genes involved in development and progression of this type of cancer.
Shuin (Kochi Medical College). The remaining papillary ACHN line was purchased from Dainippon Pharmaceutical Co. (Osaka). The RCC19 line came from a tumor with sarcomatoid transformation. The histological classifications, stages and grades of tumors employed for establishment of the nonpapillary RCC cell lines are listed in Table  I . Clinicopathological classifications were made according to the "General Rule for Clinical and Pathological Studies on Renal Cell Carcinoma" published jointly by the Japanese Urological Association, the Japanese Society of Pathology, and the Japan Radiological Society. 13 ) Cells were cultured in Dulbecco's minimal essential medium (DMEM) in Eagle's balanced salt solution supplemented with 10% fetal calf serum, at 37°C in a 5% CO 2 atmosphere. High-molecular-weight DNA was isolated from each cell line and, for reference, from peripheral lymphocytes of a normal male volunteer. 10, 12) Chromosome preparations and Q-banding Chromosomes were prepared according to standard methods and analyzed by Q-banding as previously described.
14) Karyotypes were determined according to the International System for Cytogenetic Nomenclature. 15) CGH and digital imaging CGH was performed with directly fluorochrome-conjugated DNA. 10) In brief, the DNA of each cell line was labeled with Spectrum GreendUTP (Vysis, Chicago, IL), and normal (reference) DNA was labeled with Spectrum Red-dUTP (Vysis), by nick translation. Labeled tumor and normal DNAs (200 ng each), together with 10 µg Cot-1 DNA (Gibco BRL, Gaithersburg, MD) were denatured at 70°C for 5 min in a 10 µl hybridization solution (50% formamide, 10% dextran sulfate, and 2× SSC), then hybridized to normal male metaphase chromosomes at 37°C for 48-72 h. The slides were washed for 2 min in 0.4× SSC/0.3% NP-40 at 75°C, then for 2 min at room temperature in 2 × SSC/0.1% NP-40. Air-dried slides were counterstained with 0.1 µg/ml of 4′,6′-diamidino-2-phenylindole (DAPI).
Metaphase chromosomes were captured using an epifluorescence microscope (Olympus, Tokyo) connected to a cooled charge-coupled device (CCD) camera (Photometrics, Tucson, AZ). Three-color digital images were collected from each hybridization, in 5-10 metaphase cells, and processed with Vysis/Quips CGH software (Ver. 2.1). Chromosomal regions were interpreted as over-represented (gain) if a ratio of green to red >1.2 was observed, whereas regions with a green-to-red ratio <0.8 were interpreted as under-represented (loss). Any region in which the ratio of green to red was >1.5 we interpreted as HLG indicative of gene amplification. 7, 8, 10) Heterochromatic regions near the centromeres and telomeres, and the entire Y chromosome, were excluded from analysis. FISH and chromosome painting Because we detected 
RESULTS
Cytogenetic analysis Cytogenetic findings for the 12 nonpapillary RCC cell lines that were analyzed successfully in this manner are summarized in Table I . The modal chromosome numbers ranged from near-diploid to nearpentaploid. The most consistent and recurrent abnormalities were deletions or rearrangements involving chromosome 3p, seen in ten of the cell lines (83%). Karyotyping together with painting of chromosome 5 ( Fig. 2 . The minimal common regions of gains seen most frequently in the nonpapillary RCC cell lines were at 1q23-32 (7/13; 54%), 2q22-24 (6/13; 46%), 3q22-25 (6/ 13; 46%), 5q31-33 (11/13; 85%), 7p11-15 (7/13; 54%), 7q31-35 (9/13; 69%), 8q24 (8/13; 62%), 12q15-22 (6/13; 46%), and Xq21-22 (6/13; 46%). The minimal common regions involved in losses were at 3p24-25 (11/13; 85%), 4q11-31 (8/13; 62%), 8p11-12 and 8p21-22 (9/13 each; 69%), 14q23-32 (7/13; 54%), and 18p and q (6/13 each; 46%). The smallest regions of HLG overlap were seen at 4q12 (one case, Fig. 3A ), 5p (three cases), 5q23-33 (two cases, Fig. 3C Definition of the smallest common region of 5q gains by FISH FISH was performed with 20 YACs mapped within 5q13-34, to determine the smallest common region of overlapping 5q gains among RCC149, HOKN9, and KU-Ep. In the CGH experiments these three lines had exhibited much smaller regions of 5q gain than the other cell lines (Fig. 2A) . As shown in Fig. 3D , in HOKN9 one marker chromosome exhibited triplicated twin-spot signals for YACs on 5q23-q32, from D5S494 (YAC 818C10) to D5S638 (YAC917H2), but no YAC proximal or distal to this region was amplified on the marker chromosome. Moreover, in both RCC149 and KU-Ep, the average number of signals per nucleus for YACs distal to D5S658 (mean±SD; RCC149=6.4±1.2, KU-Ep=4.9±1.6) was higher than that found for YACs proximal to D5S642 (RCC149=4.1±1.4, KU-Ep=3.7±1.7). These results indicated that the minimal region covered by overlapping 5q gains among these three cell lines lay between D5S642 and D5S673 (Fig. 4) .
Validation of increased copy number at 4q12 in RCC19
FISH on metaphase cells of RCC19 with YACs 944C7 and 972B3, which contain c-kit and PDGFRA genes respectively, showed strong signals as a homogeneously staining region (HSR) on the long arm of a marker chromosome (Fig. 3B) .
DISCUSSION
By CGH analysis we determined that loss of chromosome 3p was the most frequent aberration in the nonpapillary RCC cell lines examined. This was expected because losses of 3p are one of the most common genetic aberra- tions reported in primary nonpapillary RCCs studied by conventional cytogenetics. 3, 18) Loss of heterozygosity (LOH) analyses with restriction fragment length polymorphism (RFLP) markers have revealed that at least three putative tumor suppressor genes are present on this chromosomal arm, at 3p14, 3p21.3 and 3p25.
19) The locus at 3p25 contains the Von Hippel-Lindau (VHL) tumor suppressor gene, which is known to participate in development of sporadic renal tumors, especially nonpapillary RCCs. 20, 21) Extensive cytogenetic studies have revealed that 5q-trisomies, (3;5) translocations leading to loss of 3p13-pter, and duplication of 5q22-qter are common features of nonpapillary RCCs. 22) This finding indicated that alterations of genes at chromosomes 3p and/or 5q are associated with the development of RCCs. According to RFLP analyses, allelic duplications of chromosome 5q22 occur in about 70% of primary nonpapillary RCCs, and arise also at 5q31.1 (D5S816-D5S1480; Fig. 4) . 23, 24) Our own results, derived from CGH and cytogenetic analyses in the series of nonpapillary RCC cell lines we examined, corroborate the conclusion that multiplication of 5q, particularly at 5q31-33, is a recurrent and nonrandom chromosomal aberration in this type of tumor. Furthermore, our FISH study using a number of YACs as probes revealed that the smallest region of overlap for multiplication of 5q lies within the genomic segment between D5S642 to D5S673, suggesting that gene(s) activated by a gene-dosage mechanism in this region may play important roles in nonpapillary renal-cell tumorigenesis. Indeed, numerous genes related to cell growth or proliferation, such as PDGFRB, CSF1R, FGF1, IL9, CDC25 and CDC25C, have been mapped within this region (http:/ /rmc-www.lbl.gov/CancerMap.html). FGF1 is a critical factor for angiogenesis, 25) and over-expression of plateletderived growth factor (PDGF) as well as its receptors is common in certain forms of human cancers such as glioblastoma. 26) We confirmed over-expression of PDGFRA and PDGFRB in the RCC19 cell line, which is amplified at 4q12, by western blotting (data not shown).
DNA losses on chromosomes 4q and 14q were more frequent in our series of nonpapillary RCC cell lines than in sporadic RCCs reported elsewhere. [27] [28] [29] Monosomy 14 has been proposed as a marker for increased malignancy in RCC 30) ; other CGH studies have indicated frequent losses of chromosome 4q in RCCs with sarcomatoid transformation, i.e., the highest form of dedifferentiation in renal tissue. 31, 32) Our CGH results support a conclusion that chromosomes 4q and 14q may harbor tumor suppressors whose loss contributes to malignant progression of RCCs, because cell lines are generally established from highly aggressive neoplasms with extremely poor prognoses.
HLGs, even when detected infrequently, may highlight locations of dominant oncogenes involved in tumor progression. CGH analyses of primary nonpapillary RCCs have detected HLGs at 6p12-22, 7p21-22, and 11q22-23 in one case each. 27, 31) In the cell lines studied here, HLGs were found in eight different regions, each of them harboring a known growth-related gene (http://rmc-www.lbl.gov /CancerMap.html). By performing FISH experiments with YAC probes, we found that the HLG at 4q12 possibly involved amplifications of c-kit and PDGFRA in RCC19, a cell line established from a tumor with sarcomatoid transformation.
Papillary RCC cell lines did not show loss of 3p, but they did tend to gain whole or partial chromosomes such as chromosomes 7, 12 and 17. We confirmed these data by conventional Q-banding (data not shown) and noted their concordance with cytogenetic and CGH results obtained by other investigators.
3, 19, 33) SCC and TCC are unusual forms of renal cancer, and renal SCC usually behaves aggressively. To our knowledge CGH analysis of these two types of tumor has not previously been reported. The present study has underscored the genetic complexity and high average number of aberrations present in renal tumor cell lines. CGH analysis in this study also indicated the presence of genetic abnormalities in renal tumor that were not detected by conventional cytogenetic approaches. A comparison of our CGH data with published studies involving primary renal cancers indicates striking similarities of chromosomal gains and losses. However, ours is the first report to document frequent gains of 5q31-33 and high-level amplification of 4q12 in nonpapillary RCCs. The present CGH data should provide valuable information to guide the choice of individual cell lines for exploring target genes in regions of interest.
